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A balanced diet with sufficient essential nutritional elements is critical for maintaining a healthy
body. Both nutritional excess and deficiency are associated with disease. For example, nutritional
excess, particularly in refined carbohydrates and saturated fats, coupled with physical inactivity, can
result in chronic inflammatory conditions such as obesity and cardiovascular disease. On the other
hand, deficiencies in essential nutrients can lead to stunted growth, poor immune function and classical
conditions such as scurvy, osteoporosis, depression and xeropththalmia. The gastrointestinal (GI) track
takes in food and water, digests the food, extracts the nutrients and expels undigested/unabsorbed
material as waste. Nutrients such as amino acids, oligosaccharides, and short-chain fatty acids have
been recognized to be beneficial to the GI track and to human health in general, and they participate
in shaping the immune system and in energy metabolism [1,2]. Short-chain fatty acids (acetate,
propionate, and butyrate) are also produced naturally by the intestinal microbiome acting on prebiotics
such as oligosaccharides and other indigestible fermentable fibers [3]. GI infection by microbial, viral
or parasitic agents alters the gut microbiome and increases permeability to toxins. The microbiome
is further altered by ingested antibiotics to treat bacterial infections. Microbial invasion stimulates
inflammation, a defensive mechanism of the body’s immune system. This helps clear the invading
microorganisms. However, persistent and excessive inflammatory response is a significant risk
factor for developing various chronic inflammatory conditions and cancer, and increases the risk of
succumbing to infectious diseases, owing to T cell exhaustion [4] The collection of articles in this issue
have been compiled to help illuminate the contribution nutrients make to the prevention, treatment
and taming of a range of inflammatory and infectious diseases.
Chronic inflammatory diseases affect millions of people globally. While inflammation contributes
to the tissue healing process, chronic inflammation can lead to the loss of tissue function and organ
failure. Chronic inflammation which accompanies conditions such as chronic hepatitis, inflammatory
bowel disease and neurodegenerative disorders increases the risk of malignancy. Despite rapid
advancement in diagnostics and the availability of therapeutic options, there remains no effective
cure for patients who suffer from inflammatory diseases. Therefore, patients seek alternatives and
complimentary agents as adjunct therapies to relieve symptoms and possibly prevent consequences of
inflammation. Oz H.S. [5], has investigated the anti-inflammatory properties of green tea polyphenols
(GrTPs) with potent antioxidant activities in a variety of settings. These include their ability to inhibit
the I-κB kinase nuclear factor-kappa B (NF-κB) signaling pathway, induction of programmed cell
death (caspases, Bcl-2), release of inflammatory cytokines and production of lipid mediators of the
cyclooxygenase (Cox) system. The author reviews relevant investigations regarding protective and
adverse effects as well as possible applications for GrTPs in the treatment of chronic and inflammatory
complications. GrTPs also possess antimicrobial properties, including the ability to inhibit the
growth of Mycobacterium Tuberculosis (TB) in macrophages [6] Worldwide, approximately 2–3 billion
people are infected with TB and 5–15% of these individuals will develop some form of active TB.
Using a structured questionnaire, Soh A.Z. et al. [7] investigated the effect of drinking black or
green tea, or coffee on the risk of TB activation in a prospective population-based cohort involving
63,257 tea-drinking Singaporean Chinese. With a mean follow-up period of 16.8 years, the authors
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reported that drinking black or green tea was associated with a dose-dependent reduction in the risk
for TB infection. This association was not evident with coffee or caffeine intake. The authors concluded
that regular tea drinking is associated with reduced risk of active TB.
Inflammatory bowel disease (IBD), predominantly Crohn’s disease and ulcerative colitis, affects
1.8 million people in the US and there is no available cure. Although environmental factors have been
implicated in the etiology of IBD, a breakdown in immune homeostasis, caused by a dysregulated
adaptive immune response against intestinal bacterial flora in genetically predisposed individuals,
is believed to be a key pathogenetic factor [8,9]. Crohn’s disease is frequently a progressive disease.
Up to half of these patients require surgical interventions within about 10 years of diagnosis and
over 75% of these operated patients require at least one further surgery in their lifetime. Currently,
guidelines for nutrition in general surgery also apply to Crohn’s patients. To minimize the risk of
surgery, it is necessary to optimize the nutritional status for these patients. The systematic review by
Grass F. et al. [10] investigated preoperative nutritional support in adult Crohn’s patients between
1997 and 2017 and aimed to overview screening modalities, routes of administration and expected
benefits in these patients. They selected 29 studies of which were original and 15 were review articles.
Malnutrition was found to be a major risk factor for postoperative complications, and both enteral and
parenteral routes were efficient in decreasing postoperative morbidity. The authors recommended that
the route of administration should be chosen based on disease presentation and the patients’ condition.
Further studies are needed to strengthen these evidences. Further, IBD patients may be at risk of
experiencing vitamin B (Vit B) and folate deficiencies owing to malabsorption in the IBD-affected
intestines. However, an association between IBD and serum folate and Vit B12 concentrations remains
controversial. A multiple database meta-analysis performed by Pan Y. et al. [11] to compare serum
folate and Vit B12 concentrations in IBD compared to controls revealed that the average serum folate
concentration in IBD patients was significantly lower than controls. Interestingly, this difference was
only observed with ulcerative colitis patients, but not with Crohn’s disease patients. No difference was
detected for the mean serum Vit B12 levels. The authors concluded that folate deficiency might play a
role in the development of IBD, although the data did not indicate causation. The authors suggested
that folate and Vit B12 supplementation in IBD patients might improve their nutritional status and
prevent other conditions.
Dietary considerations are important in IBD as nutritional factors may be directly involved in the
pathogenesis and recurrence of IBD. Furthermore, dietary factors may also influence the treatment of
IBD. Exclusive enteral nutrition (EEN) has been shown to have beneficial effects in various conditions
including in Crohn’s disease, and this has been recommended in Europe to be the first-line therapy for
inducing remission in pediatric luminal Crohn’s disease [12–14]. However, the mechanism of action
is elusive. One possibility is that EEN could alter the microbiota in the patients. Gatti S. et al. [15]
reviewed 14 different clinical trials, involving 216 Crohn’s patients, which investigated the effect EEN
had on the microbiota. Interestingly, patients on EEN had a profound decrease in microbiota diversity,
which switched back to their natural status upon conclusion of EEN. The EEN appeared to cause
metabolomic changes. Despite the interesting finding, inconsistencies were detected between studies
in the effect EEN had on specific bacterial strains and this awaits further microbiological analysis using
newer techniques such as next-generation DNA sequencing.
Probiotics and synbiotics are used to treat chronic inflammatory diseases such as IBD.
The probiotics and synbiotics effects have been studied on chronic intestinal diseases in in vitro animal
models and in humans in randomized clinical trials. Probiotic strains and their cell-free supernatants
reduce the expression of pro-inflammatory cytokines via actions which are principally mediated
by toll-like receptors. Probiotic administration improves clinical symptoms, histological alterations,
and mucus production in most of the evaluated animal studies. Probiotic supplementation appears to
be well tolerated, effective and safe in IBD patients. For instance, Bifidobacterium longum improved
clinical symptoms in patients with mild to moderate active colitis. However, some results suggest that
caution should be taken when administering these agents in the relapsed stages of IBD. In addition, no
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effects are reported on chronic enteropathies. Consequently, although probiotics are shown to provide
benefits, Plaza-Díaz J [16] suggested that the risks and benefits should be carefully assessed before
initiating therapy in these patients. Further studies are required to understand the exact mechanism
by which probiotics and synbiotics affect these diseases.
Obesity has become a global problem. One of the emerging issues is the link between high
pre-pregnancy body mass index (BMI) and an increased risk of adverse pregnancy outcomes.
There have been limited studies regarding the relationship between pre-pregnancy BMI and the
inflammatory potential of the diet during pregnancy. Shin D. et al. [17] included 630 pregnant women
from the U.S. National Health and Nutrition Examination Survey (NHANES) with cross sectional
examinations from 2003 to 2012. Pre-pregnancy BMI was calculated based on self-reported weight and
measured height. The authors reported that women with pre-pregnancy obesity (high-BMI) are more
likely than those with normal weight to have high dietary Inflammatory Index and elevated levels of
C-reactive protein (CRP).
Micronutrient homeostasis is a key factor in maintaining a healthy immune system. Zinc (Zn) is an
essential micronutrient that is involved in the regulation of the innate and adaptive immune responses.
Malnutrition is the main cause of Zn deficiency which leads to cell-mediated immune dysfunctions
and other manifestations [18]. Consequently, immune dysfunction leads to a worse outcome toward
bacterial infection and sepsis. Zn is required for pathogen-eliminating signal pathways leading to
neutrophil extracellular traps formation, as well as cell-mediated immunity over humoral immunity.
Zn deficiency plays a role in inflammation to damage the host tissues. Zn is involved in the modulation
of the proinflammatory response by targeting NF-κB, a transcription factor that is the master regulator
of proinflammatory responses. It is also involved in controlling oxidative stress and regulating
inflammatory cytokines. Zn is critical for sustaining proper immune function. Gammoh N.Z. and Rink
L. [19] review the role of zinc and its deficiency during infections and inflammatory responses and
modulation of the immune system.
Copper (Cu) is another essential trace element that is required for development. Infections alter
Cu and Zn metabolism, deficiencies of which can increase infection risks. Wisniewska M. et al. [20]
conducted a prospective observational case-control study in 21 infected and 23 control term and
preterm newborns. Median concentration of Cu at birth (day 1) was 522.8 µg/L, and Zn was
1642.4 µg/L. Cu and Zn correlated positively with gestational age in control newborns. The authors
concluded that infections affect the trace element homeostasis in newborns; while serum concentration
of Zn is reduced, Cu and CRP levels are increased. The Cu/Zn ratio may constitute of a meaningful
diagnostic biomarker for early-onset of infections. Selenium is a specific trace element and essential
for normal metabolism. Minor selenium deficiency is accompanied by health defects whereas severe
deficiencies are associated with immunodeficiency, affecting both cell-mediated and humoral immune
functions. Selenium supplementation improves immune function in depleted individuals. Pregnant
women and infants are at risk for selenium deficiency, with negative effects on immune and brain
function. Varsi K. et al. [21] investigated selenium levels in two different groups: (1) 158 healthy
women who had never had any children; and (2) 140 women with singleton pregnancy who were
followed from pregnancy week 18 through to 6 months postpartum. Prevalence of infant infection was
reported by the mothers from 6 weeks to 6 months of age and neurodevelopment of the infants were
assessed using the Parental Questionnaire Ages and Stages at 6 months of age. The authors reported
that low maternal selenium status (≤0.78 µmol/L) at week 36 of pregnancy was associated with an
increased risk of infection in the babies during the first 6 weeks of age and low maternal selenium
status (≤0.90 µmol/L) in pregnancy week 18 was associated with a lower psychomotor growth scores
at 6 months of age. The authors recommended that maternal serum selenium should be greater than
0.90 µmol/L in pregnancy week 18 and 0.78 µmol/L in pregnancy week 36 to benefit the infants.
Chronic pancreatitis leads to pancreatic cancer, one of the most aggressive forms of cancer. Since
pancreatic cancer cell lines express high levels of insulin-like growth factor (IGF-I and the IGF-I
receptors that stimulate cell proliferation, angiogenesis and the invasiveness of cancer cells [22,23]
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it is possible that IGF-I and related growth factors could play a role in promoting pancreatic cancer.
Gong Y. et al. [24], in a meta-analysis study, investigated the association between serum concentration
of IGF-I and the risk of pancreatic cancer. Ten studies, published between 1997–2013, which met
their inclusion criteria were selected from Medline and EMBASE databases. The authors found
no correlation between serum concentrations of IGF-I and -II, IGFBP-1 and -3, and IGF-I/IGFBP-3
ratio with risk of pancreatic cancer. Thus, serum IGF-I, IGF-II, IGFBP-1 and IGFBP-3 as well as the
IGF-I/IGFBP-3 ratio may not be associated with the development of pancreatic cancer. Further studies
are required to confirm these findings.
Ginseng is an herbal supplement with a wide-range of medicinal effects and low side effects.
Ginsenoside (Rg1) is one of the major active ingredients of ginseng with some beneficial effects in
neurodegenerative diseases such as Alzheimer’s disease. Furthermore, Rg1 has anti-inflammatory
effects. Given these actions, it is possible that Rg1 may have therapeutic value against osteoarthritis,
a condition that is characterized by degenerative changes and inflammatory responses in chondrocytes.
Cheng W. et al. [25] assessed the anti-inflammatory effects of Rg1 in human chondrocytes and whether
Rg1 was able to reduce articular cartilage damage in a rat model of osteoarthritis. The authors reported
that Rg1 suppressed IL-1β-induced inflammatory responses in human chondrocytes and reduced
disease activity in the joints of the rats.
The microbiota affects the functioning of physiological, metabolic and immunological process.
For instance, microbiota regulates the growth and functions immune cells in the intestines. Evidence
indicates that alteration in the gut microbiota can influence infectious and inflammatory diseases.
Bacteria that reside on the mucosal surface or within the mucosal layer interact with the host immune
system. Thus, a healthy gut microbiota is essential for the development of mucosal immunity. In HIV
patients and those with controlled viremia by using antiretroviral drugs their gut microbiome is
different than those uninfected HIV controls. Recent data suggest the patients with dysbiosis may have
a breakdown in their gut immunological activity, causing systemic bacterial diffusion and inflammation.
Treating GI tract disorders become difficult tasks in HIV-infected patients and those on antiretroviral
drugs. Therefore, trails are investigating the ability of probiotics to modulate epithelial barrier
functions, microbiota composition, and microbial translocation. D’Angelo C. et al. [26] conducted
a review on the use of probiotics to treat HIV-induced gastrointestinal tract disorders and in improving
gut-associated lymphoid tissue (GALT) immunity.
The beneficial properties of pistachio nuts have been extensively reported from pistachio
polyphenolic extracts in nuts, resins and leaves. These effects include antioxidant and anti-inflammatory,
antipyretic, antibacterial and antiviral, and are used for to treat infections, eczema, asthma, kidney
stones, diarrhea/GI complications and abdominal pain. Paterniti I. et al. [27] investigated the
anti-inflammatory and anti-oxidative stress properties of polyphenolic extracts from “raw pistachios”
and “roasted, salted pistachio” utilizing lipopolysaccharide (LPS) stimulated monocyte/macrophage
cell line J774 and carrageenan induced inflammatory paw edema in rat model. The authors found
anti-inflammatory and antioxidant properties of pistachio at lower doses than those reported before.
The data support beneficial effects associated with consumption of pistachios.
Pomegranate (Punicagranatum), a phytochemical rich fruit, has been used for centuries to prevent
and treat inflammatory conditions. Mandal A. et al. [28] previously reported that pomegranate
extract inhibited dimethylbenz (a) anthracene (DMBA)-initiated rat mammary tumorigenesis
by anti-proliferative actions and apoptosis. This is a continuation of their previous study to
investigate the mechanism of anti-inflammatory action for pomegranate extract in the same model.
The authors demonstrated that pomegranate emulsion was able to prevent DMBA-evoked mammary
carcinogenesis though anti-inflammatory mechanisms by inhibiting NF-κB while upregulating
Nrf2 signalling.
L-Arginine is a non-essential amino acid and nitrogen carrier for the synthesis of urea, polyamines,
proline, and other proteins. Arginine has immune-regulatory and anti-inflammatory properties.
Consequently, it is frequently administered to critically ill patients with sepsis. Yeh C-L and her
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group [29] investigated the influence of intravenous arginine administration to alter circulating
proangiogenic cells and remote lung injury in mouse model of polymicrobial sepsis induced by
cecal ligation and puncture. The authors demonstrated that arginine administration promoted
mobilization of circulating proangiogenic cells while down-regulating the sepsis-induced production
of inflammatory cytokines and expression of angiopoietin 1 and 2, and their receptor, Tie-2 mRNA in
lungs. The authors suggested that more studies are required to determine whether their observations
are involved in mediating the beneficial effects of arginine.
Vitamin D (Vit D), a fat-soluble steroid and a pro-hormone, is produced endogenously in the skin
by a direct action of ultraviolet sunlight, and a portion delivered through dietary intake. Two forms of
Vit D supplements available over-the-counter are ergocalciferol (Vit D2) and cholecalciferol (Vit D3).
Vit D2 is commonly added to foods; whereas, Vit D3 is mainly synthesized in the skin and present in
food animal products. Numerous studies have suggested the importance of Vit D to protect against
diseases including obesity and malignancies. Vit D production and its receptor have been reported in
multiple tissues, with a vital role in promoting the immune system. Rickets, a defect in bone growth in
children, due to Vit D deficiency, was first recognized in 1650. From 1930s, Vit D2 has been added to
milk in U.S. and Europe to eliminate rickets. Vit D deficiency is highly prevalent throughout the world,
affecting host immunity leading to an increased incidence and severity of several infectious diseases.
Vit D deficiency may be caused by different drugs’ interaction including steroids, chemotherapies
and lack of sunlight exposure. Yet, high doses of Vit D supplements are linked with an increased
risk of fractures, kidney stones and certain cancers. Gois P.H.F. et al. [30] reviewed recent literature
on the relationship between Vit D and the immune system, Vit D status and the risk of contracting
infectious diseases such as TB, respiratory tract infections and fungal infections, and Vit D status and
sepsis, and disease progression and mortality in human immunodeficiency virus-infected patients.
In addition, the authors reviewed the outcomes of Vit D supplementation as a treatment/prophylaxis
in the above mentioned diseases/conditions. Overall, there appears to be lack of agreement between
results from these investigations.
Dendritic Cells (DC) are vital for antigen presentation and initiation of an adaptive immune
response against hostile infection as well as immune tolerance for harmless/beneficial microbiota.
Food products can modulate the inflammatory status of intestinal DCs. Quercetin is a phytochemical
(flavonoid), which can suppress the secretion of inflammatory cytokines, antigen presentation and
DCs migration towards the draining lymph nodes. De Santis S. et al. [31] recently identified Secretory
Leukocyte Peptidase Inhibitor (Slpi) expression to be required for quercetin to inhibit the secretion
of proinflammatory cytokines and chemokines. Quercetin-enriched food was found to be able to
induce Slpi expression in the ileum, while little effects are detectable in the duodenum. Slpi expressing
cells are located at the tip of the intestinal villi, as quercetin exposure could be more efficient for
DCs projecting “periscopes” in the intestinal lumen. The data suggest that quercetin could suppress
inflammation in ileo-colonic tract.
Toxoplasmosis is a common foodborne and congenital disease, caused by Toxoplasma gondii,
an apicomplexan microorganism which infects muscle, neural tissue, and brain, in humans and
animals [32]. Toxoplasmosis has been reported to be associated with behavioral and cognitive
modulation yet the mechanism of action is not well known. There is some evidence which suggests that
Toxoplasma extracts folate from neurons. Since reduced folate availability is known to be associated with
an increased risk of neurodevelopmental disorders, neurodegenerative diseases, and cognitive decline,
Berrett A.N. et al. [33] analyzed data from the third National Health and Nutrition Examination Survey
to determine the associations between Toxoplasma infection, multiple folate-cycle factors, and cognitive
function in adults aged 20 to 59 years in United States. The data suggest that Toxoplasma infection
affected levels of folate and/or Vit B-12 in brain to alter cognitive functioning.
Millions of people are infected with Hepatitis C virus (HCV) which may lead to hepatocellular
carcinoma. The mechanism by which HCV infection affects adipokines in the host remains unclear.
Chang M-L et al. [34] presented a prospective trial with 450 patients with genotype 1 and 2 who
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had completed anti-HCV therapy. Patients surveys were used to assess pre-therapy and 24-week
post-therapy and levels of adipokines including leptin, adiponectin and plasminogen activator
inhibitor-1 (PAI-1). The authors reported specific associations between some of these parameters
and suggested that HCV infection could mask other associations e.g., between increased adipokines
levels and metabolic and hepatic profiles.
A major cause of admission into pediatric intensive care unit (ICU) is severe
inflammatory/infections and sepsis. The metabolic response to stress and infection correlates
with the severity of insult and energy requirement obtained from protein, fats and carbohydrates.
The nutritional status in the admitted children tends to deteriorate during the course of the illness and
this has a negative impact on clinical outcome. Thus, it is important to accurately determine the energy
requirements in the ICU in order to avoid under- or over-feeding. De Cosmi V. et al. [35] discussed
the metabolic changes in critically ill children and the notion for personalized pediatric nutritional
interventions. The authors report the major role for macronutrients, blood glucose levels and the acute
phase proteins by means of indirect calorimetric procedure. Authors concluded that personalized
nutritional interventions in these patients are needed to use glucose/fat balance to reduce catabolic
consequences in critical stages and speed their recovery.
Parkinson’s disease is a neurological disorder characterized by neuroinflammation, loss of
dopaminergic neurons within the midbrain. Due to insufficient therapies and adverse effects of
conventional drugs, there is an urge for use of new unconventional interventions for the treatment
of Parkinson’s. Atractylenolide-I (ATR-I) is a major bioactive ingredient isolated from the plant
rhizomes of Atractylodes Macrocephala, also known as “Baizhu”, a traditional Chinese medicine used
for anti-gastrointestinal dysfunctions and has anti-oxidant and anti-cancer activity. More S and
Choi D-K [36] investigated the anti-neuroinflammatory mechanisms of ATR-I in in vitro and in vivo
models of Parkinson’s disease. Intraperitoneal administration of ATR-I decreased microglial activation
and protected dopaminergic neurons. In vitro, ATR-I inhibited NF-κB activation and enhanced the
expression of hemoxygenase-1. The authors argue that ATR-I may be useful as a new therapeutic
agent for Parkinson disease.
Neuromuscular diseases (NMDs) are a heterogeneous group of acquired or inherited syndromes.
NMDs frequently accompany nutritional complications. Salera S. et al. [37] argued that with the
prolongation of survival in patients with NMDs, it is important to consider nutritional issues
in these patients. These include over-nutrition, glucose metabolism, mobility, respiratory and
cardiologic functions. Hypo-nutrition affects muscles and ventilatory function, constipation and
other GI disorders, chewing/swallowing difficulties as risk factors for aspiration which predisposes to
infections, respiratory complications, osteoporosis and increased risk of fractures. Focusing on the care
of children with Duchenne muscular dystrophy, the authors reported that appropriate nutritional care
can improve the quality of life in these patients. Further studies are needed to investigate the relevance
of over-nutrition and under-nutrition, GI, infections dysphagia and reduced bone mass in the different
types of neuromuscular diseases and information on appropriate percentiles of weight, height, body
mass index and body composition are critical for improved the management of these patients.
Respiratory tract infections are the most common infections in children and adults. Recurrent
respiratory tract infections are prevalent mostly in early childhood, causing high indirect and direct
costs on the healthcare system. Recurrent respiratory tract infections are usually the consequences of
immature immunity in children and immunosuppressed complications in adults with high exposure
to various respiratory pathogens. Biologically active polysaccharides like β-glucans are extensively
studied as natural immunomodulators, anti-inflammatory, and anti-infectious activities. Jesenak M. et
al. [38] reviewed the use of β-glucans as possible therapeutic and preventive approach in managing
and preventing recurrent respiratory tract infections in children (β-glucans from Pleurotus Ostreatus),
adults (yeast-derived β-glucans), and in elite athletes (β-glucans from Pleurotus Ostreatus or yeast).
Finally, a balance and vigorous gut microbiota is necessary to support health and growth in
host. Overgrowth of gut microbial or pathogens can change ecosystem, and compromise gut integrity
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to initiate GI complications. So far there is no safe and effective modality against GI pathogenic
coccidiosis. Antibiotic additives routinely fed to food animals to protect against infection, will
inevitable enter the food chain, contaminate food products and pass to the consumers. A century
after the original discovery of poultry coccidiosis, Oz H.S. [39], introduces mechano-chemically
altered coccidial organisms with distinct ultrastructures, but without abolishing their immunogenicity.
These aberrant organisms were tolerated by cyclophosphamide immunodeficient-animals yet were
non-pathogenic, and provide novel immune-protection in immune-intact-animals against pathogenic
challenges which included diarrhea, malnutrition and weight loss. This study warrants further
investigations toward vaccine production. In conclusion, this Special Issue includes a collection of
innovative articles from basics, translational findings and clinical trials as well as reviews into the
relationship between infectious/inflammatory diseases and nutrient. Prospective clinical trials, novel
diagnostic, preventive and therapeutic modalities which are discussed can aid the development of
nutritional strategies for the treatment as well as prevention of inflammation and infection. Finally,
the original reviews are of particular interest to help in advancing our understanding in signaling
pathways, molecular and biochemical mechanisms behind the effects of nutrients on inflammatory
and infectious diseases. Different nutritional and dietary life styles, whether poor or lacking essential
nutritional elements, as well as excess intake, can result in inflammatory complications and loss of
function. Nutritional deficiency is linked with several infectious and inflammatory diseases as a cause
or consequence. Studies indicate nutrients, such as amino acids, oligosaccharides, and short-chain
fatty acids exert inhibitory and anti-inflammatory functions. Gastrointestinal (GI) infections alter gut
microbiome and increase permeability to toxins. Various invasions by microbial, viral and parasitic
agents stimulate inflammation, a defensive mechanism of the body’s immune system. Other stimuli
include environmental, oxidative stress, aging and the physiological process. Long-lasting persistent
and excessive inflammatory response is a significant risk factor for developing various chronic
inflammatory and infectious diseases. The following investigations may help to understand nutritional
contributions in the prevention, treatment and to tame certain inflammatory and infectious diseases.
Conflicts of Interest: The author declares no conflict of conflict.
Abbreviations
ATR-I Atractylenolide-I
BMI body mass index
Vit D3 cholecalciferol
DC Dendritic Cells’
Vit D2 Ergocalciferol
EEN Exclusive Enteral Nutrition
GI gastrointestinal
HCV Hepatitis C virus
IBD Inflammatory bowel disease
IGF insulin-like growth factor
ICU Intensive care unit
LPS lipopolysaccharide
NMDs Neuromuscular diseases
PAI-1 plasminogen activator inhibitor-1
vit Vitamin
RTIs Respiratory tract infections
RV Rotaviruses
Toxoplasma Toxoplasma gondii
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